CClinicalTrials.gg
CompletedNCT03949010Updated May 16, 2019

Investigation of the Effectiveness of Muscle Inhibition and Space Correction Techniques of Kinesiotaping Method in Female Patients With Myofascial Pain Syndrome Related to Upper Trapezius Active Trigger Points

An interventional study of Kinesiotaping with space correction technique and Kinesiotaping with muscle inhibition technique in Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP), sponsored by Dilşad Sindel. Completed. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2019-05-16.

Sponsored by Dilşad Sindel · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 5 months after the study started (first participant enrolled Dec 2013, registered May 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine the advantage of each technique over another.

Read the detailed description

The investigators conducted a prospective, randomized, controlled trial involving 93 female patients with MPS related to upper trapezius TPs and randomized the patients to KT treatment group with space correction technique and home exercise program (KSCT, n=20), KT treatment group with muscle inhibition technique and home exercise program (KMIT, n=24) and control group (CG, n=27) which received home exercise program only. Patients were evaluated by numerical rating scale (NRS) for their average and maximum pain intensity, Turkish version of neck disability index (NDI), and short form-36 (SF-36) scales. Statistical tests were conducted at the 0.05 significance level for all outcome measures.

02

Conditions studied

  • Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP)

Keywords

  • Myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 93 is above the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

This is the only study on the registry with Dilşad Sindel as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • being female
  • being aged between 18 and 45 years old
  • not being in menopausal period
  • having pain in upper trapezius region
  • determining a taut band in examination
  • having at least one active TP in this taut band
  • the pain produced by palpation of this TP is the pain that the patient complains
  • painfull restriction of cervical lateral flexion
  • having pain score 4 or more according to NRS
  • signing informed consent.

Exclusion criteria

Exclusion Criteria:

  • having major surgery or trauma related to the musculoskeletal system (primarily including the spine and upper extremity)
  • having any operative history including the head and neck region
  • having a neuromuscular disease
  • having an active rheumatic disease
  • having a systemic disease (diabetes, hypothyroidism, infection, malignancy...)
  • having any pathology related to musculoskeletal diseases -especially including the cervical region- (cervical discopathy, cervical spondylosis, pathologies related to shoulder joint and surrounding soft tissues, scoliosis, kyphosis, limb length discrepancy, polio sequelae, developmental hip dysplasia...)
  • having serious psychological problems (having score of 30 or more from Beck Depression Inventory)
  • being obese (Body Mass Index≥30 kg/m2)
  • having allergy to kinesiotapes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
93 participants (actual)

Study arms

  • Experimental
    Kinesiotaping with space correction technique

    Other: Kinesiotaping with space correction technique · Other: Home exercise program

  • Experimental
    Kinesiotaping with muscle inhibition technique

    Other: Kinesiotaping with muscle inhibition technique · Other: Home exercise program

  • Active comparator
    Home exercise program

    Other: Home exercise program

Interventions

  • OtherKinesiotaping with space correction technique

    Kinesiotaping with space correction technique twice per week for two weeks along with home exercise program

  • OtherKinesiotaping with muscle inhibition technique

    Kinesiotaping with muscle inhibition technique twice per week for two weeks along with home exercise program

  • OtherHome exercise program

    Home exercise program which consists of stretching exercises towards neck area

06

What researchers measure

Primary outcomes

  1. Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks

    Pain intensity mesaurement via Numerical Rating Scale, range between 0 to 10, higher scores indicating more pain intensity

    Time frame: Initial assessment, First week, second week, sixth week

  2. Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

    Functional status measurement via Neck Disability Index

    Time frame: Initial assessment, second week, sixth week

  3. Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks

    Quality of life measurement via Short Form-36

    Time frame: Initial assessment, second week, sixth week

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03949010
Lead sponsor
Dilşad Sindel
Responsible party
Dilşad Sindel (Professor, MD, Istanbul University) — Sponsor-investigator
First posted
May 14, 2019
Start date
Dec 2013
Primary completion
Dec 2014
Completion
Dec 2014
Last update
May 16, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion